Abdulrahman Alwhaibi
-
- MicroRNA in disease regulation 3
- Cancer-related molecular mechanisms research 3
-
- Pharmaceutical Practices and Patient Outcomes 3
-
- Cancer-related gene regulation 6
- PI3K/AKT/mTOR signaling in cancer 4
- Retinoids in leukemia and cellular processes 3
- Metabolism, Diabetes, and Cancer 3
-
- Pharmaceutical studies and practices 3
- Co-authors
- Payaningal R. SomanathArti VermaMir S. AdilSandeep ArthamFei GaoWajid SyedHarika SabbineniSultan Alghadeer
- Cited by
- NeurologyCancer ResearchPharmacology
- Journals
- Saudi Pharmaceutical Journal (7 papers)Frontiers in Public Health (3 papers)Journal of Clinical Medicine (3 papers)
- Partner nations
- Saudi ArabiaUnited StatesChina
In The Last Decade
Abdulrahman Alwhaibi
46 papers receiving 477 citations
Peers
Comparison fields: 5 of 104
- Neurology 42
- Cancer Research 69
- Pharmacology 34
- Geriatrics and Gerontology 15
- Applied Microbiology and Biotechnology 6
Countries citing papers authored by Abdulrahman Alwhaibi
This map shows the geographic impact of Abdulrahman Alwhaibi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abdulrahman Alwhaibi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abdulrahman Alwhaibi more than expected).
Fields of papers citing papers by Abdulrahman Alwhaibi
This network shows the impact of papers produced by Abdulrahman Alwhaibi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abdulrahman Alwhaibi. The network helps show where Abdulrahman Alwhaibi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Abdulrahman Alwhaibi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 3 | |
| 7 | 2023 | 2 | |
| 8 | 2023 | 3 | |
| 9 | 2023 | 2 | |
| 10 | 2023 | 3 | |
| 11 | 2022 | 3 | |
| 12 | 2022 | 11 | |
| 13 | 2022 | 5 | |
| 14 | 2022 | 7 | |
| 15 | 2021 | 4 | |
| 16 | 2021 | 5 | |
| 17 | 2019 | 70 | |
| 18 | 2019 | 43 | |
| 19 | 2019 | 14 | |
| 20 | 2018 | 38 |
About Abdulrahman Alwhaibi
Abdulrahman Alwhaibi is a scholar working on Geriatrics and Gerontology, Endocrine and Autonomic Systems and Applied Microbiology and Biotechnology, having authored 48 papers that have together received 484 indexed citations. Recurring topics across this work include Cancer-related gene regulation (6 papers), PI3K/AKT/mTOR signaling in cancer (4 papers), MicroRNA in disease regulation (3 papers), Retinoids in leukemia and cellular processes (3 papers), Cancer-related molecular mechanisms research (3 papers), Pharmaceutical Practices and Patient Outcomes (3 papers), Metabolism, Diabetes, and Cancer (3 papers) and Pharmaceutical studies and practices (3 papers). The work is most often cited by research in Neurology (42 citations), Cancer Research (69 citations) and Pharmacology (34 citations). Abdulrahman Alwhaibi has collaborated with scholars based in Saudi Arabia, United States and China. Frequent co-authors include Payaningal R. Somanath, Arti Verma, Mir S. Adil, Sandeep Artham, Fei Gao, Wajid Syed, Harika Sabbineni, Sultan Alghadeer, Salmeen D. Babelghaith and Adviye Ergul. Their work appears in journals such as Saudi Pharmaceutical Journal, Frontiers in Public Health, Journal of Clinical Medicine, International Journal of Environmental Research and Public Health and Biochemical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.